NASDAQ:DRNA - Dicerna Pharmaceuticals, Inc.
$13.79
 $0.04
+0.29%
4:00PM EDT
2019-04-18
Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. The Company is focused on the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. The Company uses its RNAi technology platform to build a pipeline in these therapeutic areas. The Company develops dacryocystorhinostomy (DCR)-Primary Hyperoxaluria Type 1 (PH1) for the treatment of PH1 by targeting the gene encoding the liver enzyme glycolate oxidase. The Company uses its dicer substrate RNA (DsiRNA)-EX Conjugate technology to develop a subcutaneously injected treatment for PH1. The Company develops DCR-MYC for the treatment of MYC-related cancers, including hepatocellular carcinoma (HCC) and pancreatic neuroendocrine tumors (PNET). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  DRNA     avg for
industry  
  avg for
sector  
42 stocks weight:  40. 78   199. 07   233. 87  
42 stocks rank:  2. 40 K 1. 43 K 1. 06 K
# analyst opinions:  7. 00   14. 48   14. 09  
mean recommendation:  1. 70   2. 09   2. 01  

quick ratio:  4. 29   5. 29   1. 92  
current ratio:  4. 31   5. 64   2. 40  

target price low:  18. 00   84. 50   115. 74  
target price avg:  23. 57   110. 73   137. 39  
target price high:  30. 00   136. 41   157. 80  
1-yr high:  17. 69   114. 11   138. 85  
last close:  13. 79   87. 56   116. 78  
50-day avg:  12. 73   95. 43   123. 53  
200-day avg:  13. 19   94. 13   121. 20  
1-yr low:  9. 67   72. 67   98. 41  
volume:  198. 50 K 2. 43 M 4. 85 M
50-day avg volume:  562. 34 K 2. 72 M 4. 97 M
200-day avg volume:  559. 03 K 2. 90 M 4. 58 M

1-day return:  0. 29 % -0. 40 % 0. 07 %
this week return:  -4. 90 % -5. 72 % -4. 11 %
12-wk return:  35. 86 % 1. 78 % -0. 04 %
52-wk return:  41. 42 % 10. 81 % 14. 09 %

enterprise value (EV):  692. 68 M 51. 19 B 117. 96 B
market cap:  941. 36 M 43. 00 B 104. 52 B
EBITDA:  -60. 45 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -11. 46   4. 34   13. 27  
enterprise/revenue (EV/R):  112. 16   68. 16   13. 68  
total revenue:  6. 18 M 10. 61 B 38. 24 B
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -88. 85 M 2. 20 B 4. 21 B

shares outstanding:  68. 27 M 570. 91 M 1. 24 B
shares:  39. 45 M 571. 02 M 1. 23 B
shares short:  5. 91 M 9. 93 M 16. 79 M
shares short prior month:  5. 65 M 9. 96 M 16. 58 M
short ratio:  6. 93   5. 31   3. 30  
short % of float:  16. 84 % 5. 81 % 2. 61 %
total cash/share:  4. 43   11. 13   9. 30  
total cash:  302. 63 M 6. 70 B 7. 10 B
free cash flow:  -51. 00 M 3. 58 B 4. 74 B
operating cash flow:  18. 30 M 4. 14 B 6. 32 B

book value:  2. 94   12. 76   26. 84  
price/book:  4. 69   3. 08   -1. 74  
operating margins:  -991. 26 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -18. 11 % --- ---
1-yr mean volatility:  0. 20 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 60   2. 39   4. 08  
forward EPS:  -1. 18   3. 97   7. 14  
P/E:  -8. 63   13. 59   22. 83  
forward P/E:  -12. 29   -20. 05   14. 49  
PE/G:  -0. 17   -1. 46   1. 68  
growth:  49. 60 % 126. 81 % 29. 29 %
earnings high:  -0. 06   1. 02   1. 63  
earnings avg:  -0. 22   0. 76   1. 51  
earnings low:  -0. 43   0. 47   1. 39  
revenue high:  17. 30 M 2. 68 B 10. 71 B
revenue avg:  10. 30 M 2. 59 B 10. 49 B
revenue low:  1. 50 M 2. 49 B 10. 25 B
return on assets:  -14. 44 % -2. 80 % 5. 29 %
return on equity:  -58. 89 % -18. 52 % 7. 38 %
revenue growth:  49. 60 % 92. 55 % 19. 15 %
revenue/share:  0. 11   13. 27   55. 24  

beta (1yr vs S&P500):  1. 61   1. 24   0. 93  
sharpe (1yr):  0. 74   0. 29   0. 60  

held % insiders:  8. 38 % 6. 38 % 3. 38 %
held % institutions:  91. 35 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : DRNA
.    + 2.115 =         2.115 :: INITIAL WEIGHT
.  + 108.631 =       110.746 :: inverse volume-to-price addition
.    + 39.48 =       150.226 :: spline projection addition
.    x 4.787 =       719.168 :: 13 weeks' performance factor
.    x 1.282 =       921.685 :: one-year gains+dividend factor
.    x 1.432 =      1319.875 :: industry recommendation factor
.    x 2.622 =      3461.098 :: symbol recommendation factor
.    x 1.355 =      4688.433 :: EV/R factor
.    x 0.999 =      4681.664 :: return on assets factor
.    x 0.994 =      4654.095 :: return on equity factor
.    x 2.451 =      11408.47 :: revenue growth factor
.    x 2.765 =     31539.488 :: current ratio factor
.    x 1.142 =     36016.435 :: quick ratio factor
.     x 1.07 =     38527.488 :: short ratio factor
.    x 2.047 =      78860.87 :: price-to-book factor
.    x 1.077 =     84921.963 :: 5-day avg > 200-day avg
.    x 1.116 =      94788.54 :: 5-day avg > 50-day avg
.    x 2.011 =    190653.515 :: P/E weight
.    x 1.548 =    295201.366 :: PE/G factor
.    x 1.381 =    407795.875 :: beta factor
.    x 0.745 =    303683.227 :: sharpe factor
.    x 1.579 =    479664.087 :: target low factor
.    x 1.281 =    614313.121 :: target mean factor
.    x 1.108 =    680916.945 :: target high factor
.    x 1.312 =    893123.612 :: industry 2-weeks return factor
.    x 0.921 =    822984.774 :: "drift" penalty 4 days ago
.      x 1.0 =    822681.817 :: overall "drift" factor
.    x 0.999 =    822058.327 :: largest single-day jump factor
.    x 0.295 =    242495.082 :: low price factor
.      x 1.0 =    242455.992 :: factor hist industry gain for week 15
.   cubeRoot =        62.356 :: reduced to standardize
.   - 21.578 =        40.778 :: add/subtract for performance
.                     40.778 :: FINAL WEIGHT for NASDAQ:DRNA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org